New Model Helps ID Melanoma Patients With Lymph Node Involvement

WEDNESDAY, May 3, 2023 -- A patient-centered methodology (PCM) approach outperforms conventional analysis for predicting which melanoma patients would have a positive result on sentinel lymph node biopsy (SLNB), according to a study published online...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news